China-Based Panacea Venture Hits Final Close For New Healthcare Fund At $180.5M

Login to View

Panacea Venture, a China-based venture capital firm backed by former partners of Kleiner Perkins Caufield & Byers China (KPCB China), has reached the final close of a new healthcare-focused fund "Panacea Venture Healthcare Fund I" with US$180.5 million in capital commitments.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in

China Money Network Subscription